BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20445534)

  • 21. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
    Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
    Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease.
    Bollini P; García Rodríguez LA; Pérez Gutthann S; Walker AM
    Arch Intern Med; 1992 Jun; 152(6):1289-95. PubMed ID: 1534651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
    Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
    Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
    Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
    Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9.
    Visser LE; van Schaik RH; Jan Danser AH; Hofman A; Witteman JC; van Duijn CM; Uitterlinden AG; Pols HA; Stricker BH
    Pharmacogenet Genomics; 2007 Jul; 17(7):473-9. PubMed ID: 17558303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis?
    Dincer D; Duman A; Dikici H; Arici C; Suleymanlar I; Isitan F
    Int J Clin Pract; 2006 May; 60(5):546-8. PubMed ID: 16700851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals.
    Martínez ME; McPherson RS; Levin B; Annegers JF
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):703-7. PubMed ID: 8672985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.
    Okada K; Inamori M; Imajo K; Chiba H; Nonaka T; Shiba T; Sakaguchi T; Atsukawa K; Takahashi H; Hoshino E; Nakajima A
    Hepatogastroenterology; 2009; 56(96):1665-9. PubMed ID: 20214214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of CYP2C9 genotype on pharmacokinetics: are all NSAIDs the same?
    van Oijen MG; Laheij RJ
    Gastroenterology; 2007 Dec; 133(6):2073-4; author reply 2074-5. PubMed ID: 18054587
    [No Abstract]   [Full Text] [Related]  

  • 33. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The duodenum and non-steroidal anti-inflammatory agents].
    Pippa G; Apuzzo M; Bazuro ME; Tammaro G
    Recenti Prog Med; 1990 Jun; 81(6):453-6. PubMed ID: 2251456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom.
    Lim CH; Heatley RV
    Postgrad Med J; 2005 Apr; 81(954):252-4. PubMed ID: 15811890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
    Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.